mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |